Linda Elsegood: Welcome to the LDN radio show brought to you by the LDN Research Trust I'm your host, Linda Elsegood. I have an exciting lineup of guest speakers who are LDN experts in their field. We will be discussing low-dose naltrexone and its many uses in autoimmune diseases, cancers, etc. Thank you for joining us.

This was an LDN Radio Show interview in 2022.

Linda Elsegood: Welcome to the LDN Radio Show, brought to you by the LDN Research Trust I'm your host, Linda Elsegood. I have an exciting lineup of guest speakers who are LDN experts in their field. We will be discussing low-dose naltrexone and its many uses in autoimmune diseases, cancers, etc. Thank you for joining us.

Asher Goldstein, MD - LDN Radio Show 2022 (LDN; low dose naltrexone)

Carol Petersen, RPh, CNP - Discussing Healthcare, LDN Radio Show 13 July 2022 (LDN; low dose naltrexone)

Tim - England: Eye cancer (2022) (LDN; low dose naltrexone)

Summary:

Ellen is from the United States and takes LDN for lupus, Sjogren’s, Hashimoto's and interstitial cystitis, and for pain. She is in her 70s, and began with autoimmune issues at 24. When she started LDN, she quickly had this overall feeling of feeling good, and was able to increase her activity levels greatly.

Full edited text:

Liz - Scotland: Multiple Sclerosis (MS) (LDN; low dose naltrexone)

Yusuf (JP) Saleeby, MD - LDN to help Long Covid patients; March 2022 (LDN, low dose naltrexone)

Pharmacist Michelle Moser, LDN Key to Success (LDN, low dose naltrexone)

Dr Sajad Zalzala, LDN Radio Show February 2022 (LDN, low dose naltrexone)